Pathway Financial Advisers LLC Has $1.35 Million Stake in Nutrien Ltd. (NYSE:NTR)

Pathway Financial Advisers LLC trimmed its position in Nutrien Ltd. (NYSE:NTR) by 1.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,145 shares of the company’s stock after selling 543 shares during the period. Pathway Financial Advisers LLC’s holdings in Nutrien were worth $1,349,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. AQR Capital Management LLC lifted its stake in Nutrien by 28.4% in the 2nd quarter. AQR Capital Management LLC now owns 5,348 shares of the company’s stock valued at $272,000 after acquiring an additional 1,184 shares in the last quarter. CWM LLC lifted its position in shares of Nutrien by 30.6% in the third quarter. CWM LLC now owns 7,738 shares of the company’s stock worth $372,000 after purchasing an additional 1,815 shares in the last quarter. Creative Planning boosted its holdings in Nutrien by 1.3% during the third quarter. Creative Planning now owns 36,524 shares of the company’s stock worth $1,755,000 after purchasing an additional 473 shares during the last quarter. Bourne Lent Asset Management Inc. grew its position in Nutrien by 2.8% in the third quarter. Bourne Lent Asset Management Inc. now owns 37,032 shares of the company’s stock valued at $1,780,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Vontobel Holding Ltd. increased its stake in Nutrien by 14.8% in the 3rd quarter. Vontobel Holding Ltd. now owns 23,087 shares of the company’s stock valued at $1,109,000 after buying an additional 2,979 shares during the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Stock Performance

Shares of NTR stock opened at $49.91 on Thursday. Nutrien Ltd. has a 52 week low of $43.69 and a 52 week high of $60.87. The company has a market capitalization of $24.51 billion, a price-to-earnings ratio of 33.50, a PEG ratio of 1.13 and a beta of 0.81. The company has a 50-day simple moving average of $48.91 and a 200 day simple moving average of $48.12. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27.

Analyst Ratings Changes

A number of research firms have recently commented on NTR. CIBC restated an “outperformer” rating and set a $55.00 price objective (down from $60.00) on shares of Nutrien in a research note on Tuesday, December 10th. UBS Group increased their price target on Nutrien from $51.00 to $53.00 and gave the company a “neutral” rating in a research report on Tuesday, January 28th. TD Securities decreased their price target on Nutrien from $63.00 to $61.00 and set a “buy” rating for the company in a research note on Tuesday, November 12th. Piper Sandler upped their price objective on Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Finally, Barclays reissued an “equal weight” rating and issued a $56.00 target price (up from $55.00) on shares of Nutrien in a research note on Tuesday, January 21st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat, Nutrien presently has an average rating of “Moderate Buy” and an average target price of $59.00.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.